ATE484509T1 - Antibakterielle mittel - Google Patents

Antibakterielle mittel

Info

Publication number
ATE484509T1
ATE484509T1 AT05782987T AT05782987T ATE484509T1 AT E484509 T1 ATE484509 T1 AT E484509T1 AT 05782987 T AT05782987 T AT 05782987T AT 05782987 T AT05782987 T AT 05782987T AT E484509 T1 ATE484509 T1 AT E484509T1
Authority
AT
Austria
Prior art keywords
antibacterial agents
quinoxaline
quinoline
mammals
naphthalene
Prior art date
Application number
AT05782987T
Other languages
English (en)
Inventor
William Miller
Mark Seefeld
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE484509T1 publication Critical patent/ATE484509T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT05782987T 2004-08-02 2005-08-02 Antibakterielle mittel ATE484509T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59818004P 2004-08-02 2004-08-02
PCT/US2005/027348 WO2006017468A2 (en) 2004-08-02 2005-08-02 Antibacterial agents

Publications (1)

Publication Number Publication Date
ATE484509T1 true ATE484509T1 (de) 2010-10-15

Family

ID=35839845

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05782987T ATE484509T1 (de) 2004-08-02 2005-08-02 Antibakterielle mittel

Country Status (6)

Country Link
US (1) US7655648B2 (de)
EP (1) EP1781669B1 (de)
JP (1) JP2008508359A (de)
AT (1) ATE484509T1 (de)
DE (1) DE602005024151D1 (de)
WO (1) WO2006017468A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7263501B2 (en) 2003-03-11 2007-08-28 I-Stat Corporation Point-of-care inventory management system and method
EP1845995A4 (de) * 2005-01-25 2010-03-03 Glaxo Group Ltd Antibakterielle wirkstoffe
EP1790342A1 (de) 2005-11-11 2007-05-30 Zentaris GmbH Pyridopyrazin-Derivate und deren Verwendung als Modulatoren der Signaltransduktionswege
US8217042B2 (en) 2005-11-11 2012-07-10 Zentaris Gmbh Pyridopyrazines and their use as modulators of kinases
JP2009532504A (ja) 2006-04-06 2009-09-10 グラクソ グループ リミテッド 抗菌薬
JP2009532423A (ja) 2006-04-06 2009-09-10 グラクソ グループ リミテッド 抗菌剤としてのピロロ−キノキサリノン誘導体
WO2007138974A1 (ja) 2006-05-26 2007-12-06 Toyama Chemical Co., Ltd. 新規な複素環化合物またはその塩ならびにその中間体
EP1992628A1 (de) 2007-05-18 2008-11-19 Glaxo Group Limited Derivate und Analoge von N-Ethylquinolonen und N-Ethylazaquinolonen
BRPI0810064B8 (pt) * 2007-04-20 2021-05-25 Glaxo Group Ltd compostos contendo nitrogênio tricíclico como agentes antibacterianos, composições farmacêuticas que compreendem os ditos compostos e uso dos mesmos para o tratamento de infecções bacterianas em mamíferos
EP2080761A1 (de) 2008-01-18 2009-07-22 Glaxo Group Limited Verbindungen
WO2010043714A1 (en) 2008-10-17 2010-04-22 Glaxo Group Limited Tricyclic nitrogen compounds used as antibacterials
ES2561631T3 (es) 2009-01-15 2016-02-29 Glaxo Group Limited Compuestos de naftiridin-2(1H)-ona útiles como agentes antibacterianos
EP3182973B1 (de) 2014-08-22 2019-09-18 GlaxoSmithKline Intellectual Property Development Limited Tricyclische stickstoffhaltige verbindungen zur behandlung einer infektion mit neisseria gonorrhoea
TW201722965A (zh) 2015-08-16 2017-07-01 葛蘭素史密斯克藍智慧財產發展有限公司 用於抗菌應用之化合物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2634483B2 (fr) * 1987-12-29 1994-03-04 Esteve Labor Dr Derives des acides 7-(1-azetidinyl)-1,4-dihydro-4-oxoquinoleine-3-carboxyliques, leur preparation et leur application en tant que medicaments
US5162523A (en) * 1989-07-21 1992-11-10 Hoffmann-La Roche Inc. Cephalosporin antibacterial compounds
PL366335A1 (en) 2000-07-26 2005-01-24 Smithkline Beecham P.L.C. Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
GB0101577D0 (en) 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
AU2003239302A1 (en) 2002-01-29 2003-09-02 Glaxo Group Limited Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
TW200406410A (en) * 2002-01-29 2004-05-01 Glaxo Group Ltd Compounds
US6995144B2 (en) * 2002-03-14 2006-02-07 Eisai Co., Ltd. Nitrogen containing heterocyclic compounds and medicines containing the same
AR040336A1 (es) 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
WO2004055012A1 (en) 2002-12-13 2004-07-01 Smithkline Beecham Corporation Indane compounds as ccr5 antagonists
AR042486A1 (es) 2002-12-18 2005-06-22 Glaxo Group Ltd Compuesto de quinolina y naftiridina halosustituido en la posicion 3, procedimiento para preparar el compuesto, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion .
TW200507841A (en) 2003-03-27 2005-03-01 Glaxo Group Ltd Antibacterial agents
WO2004092177A1 (en) 2003-04-09 2004-10-28 Biogen Idec Ma Inc. Triazolopyrazines and methods of making and using the same
US7550485B2 (en) 2003-10-14 2009-06-23 Wyeth Substituted N-heterocycle derivatives and methods of their use
JP2008502689A (ja) 2004-06-15 2008-01-31 グラクソ　グループ　リミテッド 抗菌剤
JP2008506695A (ja) * 2004-07-13 2008-03-06 グラクソ　グループ　リミテッド 抗細菌剤
JP2008509222A (ja) * 2004-08-09 2008-03-27 グラクソ グループ リミテッド 抗菌剤

Also Published As

Publication number Publication date
WO2006017468A3 (en) 2006-07-13
EP1781669A4 (de) 2009-03-11
US20070244091A1 (en) 2007-10-18
WO2006017468A2 (en) 2006-02-16
EP1781669A2 (de) 2007-05-09
US7655648B2 (en) 2010-02-02
EP1781669B1 (de) 2010-10-13
DE602005024151D1 (de) 2010-11-25
JP2008508359A (ja) 2008-03-21

Similar Documents

Publication Publication Date Title
ATE484509T1 (de) Antibakterielle mittel
DE60334016D1 (de) Antibakterielle mittel
WO2006002047A3 (en) Antibacterial agents
TW200507841A (en) Antibacterial agents
WO2006020561A3 (en) Antibacterial agents
WO2007016610A3 (en) Antibacterial agents
WO2006010040A3 (en) Antibacterial agents
WO2006081289A3 (en) Antibacterial agents
WO2004058144A3 (en) Antibacterial agents
DE60331849D1 (de) Antibakterielle wirkstoffe
WO2006081182A3 (en) Antibacterial agents
WO2006081178A3 (en) Antibacterial agents
ATE344799T1 (de) Piperidinderivate als antibakterielle mittel
WO2007118130A3 (en) Antibacterial agents
PE20001112A1 (es) Derivados de quinolina como agentes antibacterianos
ATE327231T1 (de) Chinolinderivate als antibakterielle mittel
AU2003251474A8 (en) Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity
ATE255104T1 (de) Quinolin-derivate und deren verwendung als antibakterielle wirkstoffe
DE602004021644D1 (de) Gyraseinhibitoren und deren verwendungen
DE60324179D1 (de) Chinoline und stickstoffhaltige derivatedavon und deren verwendung als antibakterielle mittel
ATE354585T1 (de) Antibakterielle amid-makrozyklen
NO20072890L (no) Behandling av mastitt
ATE495186T1 (de) Antibakterielle amid-makrozyklen iv
ATE433459T1 (de) Desoxo-nonadepsipeptide
WO2005118613A3 (de) Antibakterielle amid-makrozyklen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties